ZYGOMYCOSIS

Clinical trials for ZYGOMYCOSIS explained in plain language.

Never miss a new study

Get alerted when new ZYGOMYCOSIS trials appear

Sign up with your email to follow new studies for ZYGOMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

High-Dose antifungal shows promise against rare, deadly mold

Disease control Completed

This study tested a high dose (10 mg/kg/day) of the antifungal drug liposomal amphotericin B (Ambisome) in 40 people with zygomycosis, a rare but serious fungal infection. The goal was to see if this dose could control the infection, measured by complete or partial response after…

Matched conditions: ZYGOMYCOSIS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 12, 2026 12:08 UTC

ZYGOMYCOSIS

Get alerted when new ZYGOMYCOSIS trials appear

High-Dose antifungal shows promise against rare, deadly mold